SALVI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 4.613
AS - Asia 2.188
EU - Europa 2.063
SA - Sud America 300
Continente sconosciuto - Info sul continente non disponibili 127
AF - Africa 53
OC - Oceania 7
Totale 9.351
Nazione #
US - Stati Uniti d'America 4.518
SG - Singapore 782
CN - Cina 689
PL - Polonia 607
IT - Italia 308
DE - Germania 260
UA - Ucraina 253
BR - Brasile 252
HK - Hong Kong 248
FI - Finlandia 173
VN - Vietnam 155
FR - Francia 98
GB - Regno Unito 86
RU - Federazione Russa 82
IN - India 60
TR - Turchia 58
BD - Bangladesh 51
IE - Irlanda 51
CA - Canada 48
ID - Indonesia 31
MX - Messico 27
BE - Belgio 25
SE - Svezia 25
ZA - Sudafrica 21
ES - Italia 18
JP - Giappone 17
NL - Olanda 17
AR - Argentina 16
IQ - Iraq 15
PK - Pakistan 12
MA - Marocco 11
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
LT - Lituania 9
AT - Austria 8
CZ - Repubblica Ceca 8
IR - Iran 8
VE - Venezuela 7
AU - Australia 6
CO - Colombia 6
EC - Ecuador 6
GR - Grecia 6
JO - Giordania 6
UZ - Uzbekistan 6
NG - Nigeria 5
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
MY - Malesia 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
CL - Cile 3
DZ - Algeria 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
PA - Panama 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 9.226
Città #
Warsaw 606
Fairfield 459
Ashburn 458
Singapore 438
Woodbridge 290
Hong Kong 244
San Jose 234
Houston 230
Seattle 204
Jacksonville 191
Chandler 185
The Dalles 175
Cambridge 155
Wilmington 144
New York 137
Brescia 124
Beijing 116
Helsinki 116
Los Angeles 110
Ann Arbor 108
Princeton 92
Munich 89
Dallas 80
Council Bluffs 74
Dearborn 69
Nanjing 62
Lauterbourg 52
Chicago 50
Dublin 50
Istanbul 45
Columbus 39
Hanoi 36
Shanghai 35
Dong Ket 33
San Francisco 33
Ho Chi Minh City 32
Moscow 31
São Paulo 31
Milan 29
Turku 29
Buffalo 27
Des Moines 27
Frankfurt am Main 27
Orem 25
Santa Clara 25
Hebei 24
Jinan 24
Changsha 23
Jakarta 23
Brussels 22
London 22
Shenyang 22
Redondo Beach 21
San Diego 21
Nanchang 18
Brooklyn 17
Rome 17
Tianjin 17
Phoenix 16
Boston 15
Tokyo 15
Denver 14
Toronto 14
Amsterdam 13
Hangzhou 13
Jiaxing 13
Washington 13
Chennai 12
Naples 12
Salt Lake City 12
Atlanta 11
Guangzhou 11
Mexico City 11
Montreal 11
Stockholm 11
Taizhou 11
Zhengzhou 11
Da Nang 10
Dhaka 10
Johannesburg 10
Rio de Janeiro 10
San Mateo 10
Augusta 9
Lancaster 9
Nuremberg 9
Tampa 9
Kunming 8
Lappeenranta 8
Miami 8
Mumbai 8
Ningbo 8
Pune 8
West Jordan 8
Boardman 7
Haiphong 7
Orange 7
Verona 7
Ankara 6
Brno 6
Hefei 6
Totale 6.544
Nome #
TLR Signalling Pathways Diverge in Their Ability to Induce PGE2 349
Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors 327
Adaptive regulation of osteopontin production by dendritic cells through the bidirectional interaction with mesenchymal stromal cells 302
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 295
Adipokines as potential biomarkers in rheumatoid arthritis. 259
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 252
Cytokine targeting by miRNAs in autoimmune diseases 240
Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNAs in mouse 229
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Sulphurous thermal water increases the release of the anti-inflammatory cytokine IL-10 and modulates antioxidant enzyme activity. 214
Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. 198
Angiogenic and antiangiogenic chemokines 198
Dual regulation of osteopontin production by TLR stimulation in dendritic cells. 194
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 192
Palbociclib inhibits proliferation of human adrenocortical tumor cells 190
Endothelial cell-derived chemerin promotes dendritic cell transmigration. 188
The atypical receptor CCRL2 is essential for lung cancer immune surveillance 183
Role of Atypical Chemokine Receptors in Microglial Activation and Polarization. 182
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage 181
Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency 177
CCRL2 regulates M1/M2 polarization during EAE recovery phase 175
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 175
The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells 172
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement 170
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 170
Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. 164
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 162
Absence of the Fragile X Mental Retardation Protein results in defects of RNA editing of neuronal mRNA in mouse 161
Extracellular miRNAs as activators of innate immune receptors 161
IL-21 may promote Granzyme B-dependent NK/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus 154
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 150
Functional role of dendritic cell subsets in cancer progression and clinical implications 150
Chemerin in immunity 144
Pro-lymphangiogenic properties of IFN-γ-activated human dendritic cells 132
Selective induction of VEGF-A by TLR4 and TLR8 in human dendritic cells 130
Small extracellular vesicle-delivered microRNAs promote IFN-alpha secretion by plasmacytoid DCs via TLR7 130
Dendritic cell subsets in cancer immunity and tumor antigen sensing. 115
SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8 114
CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer 113
IL-21 induces granzyme B secretion by human plasmacytoid dendritic cells 113
Extracellular vesicles at the crossroad between cancer progression and immunotherapy: focus on dendritic cells 111
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation 107
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 103
The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils 103
Fine-tuning of the immunomodulatory functions of dendritic cells by the Phosphodiestherase 4 inhibitor tanimilast. 99
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs 97
Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α 94
Selective induction of vegf-a by TLR4 and TLR8 in human dendritic cells 94
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 93
Toll-like receptor (TLR) ligands differentially regulate soluble osteopontin production by human monocyte-derived dendritic cells 91
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity 85
Molecular mechanism of vegf-a secretion by alternative activated dendritic cells 85
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 85
IL-21 promotes Granzyme B-dependent NK/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus 83
Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis. 80
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 76
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer 72
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma 59
Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases 59
The RIG-I agonist M8 triggers cell death and natural killer cell activation in human papillomavirus-associated cancer and potentiates cisplatin cytotoxicity 48
SARS-CoV-2-Associated ssRNAs Activate Human Neutrophils in a TLR8-Dependent Fashion 48
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 23
Psoriatic microRNAs induce NK cell activation via an innate immune crosstalk abrogated by the Toll-like receptor 7/8 antagonist Enpatoran 17
LRRK2 Mutation Alters Dopamine D2 Receptor Localization in Induced Pluripotent Stem Cells-Derived Astrocytes From Parkinson's Disease Patients: Implications for Neuronal Damage 8
Totale 9.351
Categoria #
all - tutte 41.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022356 0 53 13 23 11 23 17 27 21 43 31 94
2022/2023496 68 25 27 46 36 107 1 65 75 0 24 22
2023/2024554 32 8 64 34 33 147 11 22 92 32 13 66
2024/20251.462 17 12 32 205 109 113 112 96 202 109 286 169
2025/20262.883 279 297 232 300 314 222 492 158 169 257 126 37
2026/2027142 85 57 0 0 0 0 0 0 0 0 0 0
Totale 9.351